High-Dose-Rate Intracavitary Irradiation in the Surgical Treatment of Cancer of the Thoracic Esophagus
Thoracic esophageal cancer upon diagnosis is frequently found to be already advanced and also to have metastasized to the lymph nodes even in the early stages. Current surgical treatment operatively excises lymph nodes in three major areas (cervical, thoracic, and abdominal). It is difficult to know whether this operative treatment always contributes to the therapeutic improvement. However, advances in surgery have led to greater understanding about the ease with which esophageal cancer metastasizes to the lymph nodes. Accordingly, extensive dissection is not very effective particularly for advanced cancer. We feel that a new approach is needed to improve therapeutic results for the treatment of advanced esophageal cancer.
KeywordsEsophageal Cancer Thoracic Esophagus Biological Effective Dose Resected Case Advanced Esophageal Cancer
Unable to display preview. Download preview PDF.
- 1.Ogoshi S, Ohmori Y, Tamiya T, Yonezawa T (1985) Preparation of isoperistaltic tube along the greater curvature with GIA instrument and its esophageal reconstruction (in Japanese). Operation 39: 1409–1415Google Scholar
- 2.Ogoshi S, Tamiya T (1992) Esophageal substitute with a thin gastric tube along the greater curvature (in Japanese). Gastroenterol Surg 15: 1549–1559Google Scholar
- 3.Isono K (ed) (1990) Survey report of the 44th annual meeting of the Japanese Society for the Diseases of the Esophagus (in Japanese). Chiba, Japan, 6, 1990Google Scholar
- 7.Hishikawa Y, Kurisu K, Taniguchi M, Kamikonya N, Miura T (1991) High-dose-rate intraluminal brachytherapy ( HDRIBT) for esophageal cancer. Int J Radiat Oncol Biol Phys 21: 1133–1135Google Scholar
- 9.UICC edited by Hermanek P and Sobin LH (1978) TNM classification of malignant tumors, 4th edn. Springer-Verlag Berlin Heidelberg, 1987Google Scholar